Vascular Endothelial vascular V Va Vas Vasc BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 10 0 0 0 0 1
Smooth Muscle smooth S Sm Smo Smoo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 5 0 0 0 0 1
Amir H. amir A Am Ami Amir BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,..,*,..,*,-,..,,,..,, 23 10 0 0 0 0 1
Michael M. michael M Mi Mic Mich BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,..,*.,..,*.,.. 16 7 0 0 0 0 1
*Division of *division * *D *Di *Div BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 *,,(), 6 10 0 0 0 0 1
David Geffen david D Da Dav Davi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 ,,;, 4 9 0 0 0 0 1
Medical Center, medical M Me Med Medi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 ,, 2 2 0 0 0 0 1
Submitted for submitted S Su Sub Subm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 10 0 0 0 0 1
Introduction. Delivery introduction. I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 8 0 0 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 () 2 9 0 0 0 0 1
been shown been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -- 2 9 0 0 0 0 1
tenuate neointimal tenuate t te ten tenu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
jury models, jury j ju jur jury BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,- 3 9 0 0 0 0 1
tion, and tion, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ,.- 3 9 0 0 0 0 1
endothelialization, we endothelialization, e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 8 0 0 0 0 1
further vascular further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
intimal hyperplasia intimal i in int inti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
induced proliferation induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
(VSMCs) via (vsmcs) ( (V (VS (VSM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()- 3 8 0 0 0 0 1
pathway. pathway. pathway. p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 1 0 0 0 0 1
Materials and materials M Ma Mat Mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 8 0 0 0 0 1
seeded and seeded s se see seed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
stimulated with stimulated s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,- 2 9 0 0 0 0 1
let derived let l le let let BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 /, 2 10 0 0 0 0 1
10, 20, 10, 1 10 10, 10, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 ,,,,/. 6 9 0 0 0 0 1
proliferation assay proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
oxyuridine uptake oxyuridine o ox oxy oxyu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 .- 2 9 0 0 0 0 1
ern immunoassay ern e er ern ern BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
signal-regulated kinase signal-regulated s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -()- 4 8 0 0 0 0 1
phorylation of phorylation p ph pho phor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 /. 2 9 0 0 0 0 1
Results. VEGF results. R Re Res Resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 .- 2 8 0 0 0 0 1
poration into poration p po por pora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -- 2 8 0 0 0 0 1
dependent manner, dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 10 0 0 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (.),(.), 8 10 0 0 0 0 1
ng/mL (P ng/ml n ng ng/ ng/m BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 /(.).- 6 8 0 0 0 0 1
blots revealed blots b bl blo blot BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 8 0 0 0 0 1
inoblastoma at inoblastoma i in ino inob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 7 0 0 0 0 1
ng/mL and ng/ml n ng ng/ ng/m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 // 2 8 0 0 0 0 1
of 30, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,/. 3 3 0 0 0 0 1
Conclusion. In conclusion. C Co Con Conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 .- 2 6 0 0 0 0 1
endothelialization, VEGF endothelialization, e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 8 0 0 0 0 1
protective function protective p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 8 0 0 0 0 1
liferation. This liferation. l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 .- 2 8 0 0 0 0 1
thelial cells thelial t th the thel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -- 2 8 0 0 0 0 1
nase pathway. nase n na nas nase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 . 1 7 0 0 0 0 1
modulator of modulator m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -- 2 8 0 0 0 0 1
ter vascular ter t te ter ter BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ... 3 10 0 0 0 0 1
Key Words: key K Ke Key Key BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 :;- 3 7 0 0 0 0 1
man aortic man m ma man man BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 ;. 2 7 0 0 0 0 1
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
The treatment the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 0 1 0 0 1
it is it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,, 2 9 0 1 0 0 1
circulation, has circulation, c ci cir circ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 0 1 0 0 1
to operative to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 0 1 0 0 1
stenting. Although stenting. s st ste sten BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 9 0 1 0 0 1
techniques have techniques t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,- 2 9 0 1 0 0 1
cess of cess c ce ces cess BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 10 0 1 0 0 1
rate because rate r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 0 1 0 0 1
hyperplasia. The hyperplasia. h hy hyp hype BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 9 0 1 0 0 1
high, with high, h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 10 0 1 0 0 1
stenting at stenting s st ste sten BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 -[] 3 10 0 1 0 0 1
endarterectomy at endarterectomy e en end enda BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 []. 3 5 0 1 0 0 1
Neointimal hyperplasia neointimal N Ne Neo Neoi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 8 0 1 0 0 1
endothelial lining endothelial e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 - 1 9 0 1 0 0 1
trolled proliferation trolled t tr tro trol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 9 0 1 0 0 1
(VSMCs) within (vsmcs) ( (V (VS (VSM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (). 3 9 0 1 0 0 1
VSMCs then vsmcs V VS VSM VSMC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 8 0 1 0 0 1
intimal layer, intimal i in int inti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ,, 2 9 0 1 0 0 1
intimal thickening. intimal i in int inti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 9 0 1 0 0 1
1 Presented 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 9 no 0 9 0 1 0 0 1
Academic Surgery, academic A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ,,,,. 5 7 0 1 0 0 1
2 This 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 9 no 0 9 0 1 0 0 1
the Veterans' the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 '()- 4 9 0 1 0 0 1
ing from ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 9 .- 2 9 0 1 0 0 1
port from port p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 . 1 5 0 1 0 0 1
3 To 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 9 - 1 8 0 1 0 0 1
dressed at dressed d dr dre dres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ,, 2 10 0 1 0 0 1
San Diego, san S Sa San San BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 ,-.-:.. 7 7 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 ,–() 4 10 1 1 0 0 0
doi:10.1016/S0022-4804(03)00254-3 doi:10.1016/S0022-4804(03)00254-3 doi:10.1016/s0022-4804(03)00254-3 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 1 11 :./-()- 7 6 1 1 0 0 0
179 179 179 1 17 179 179 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 1 1 0 0 1
0022-4804/03 $35.00 0022-4804/03 0 00 002 0022 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 11 -/$. 4 4 1 1 0 0 1
© 2003 © © © © © BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 11 .. 2 10 1 1 0 0 1
of the of o of of of BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
failure of failure f fa fai fail BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [,]. 4 7 1 1 0 0 1
Platelet-derived growth platelet-derived P Pl Pla Plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -() 3 8 1 1 0 0 1
by endothelial by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [],[],- 7 9 1 1 0 0 1
phages [7], phages p ph pha phag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [],[] 5 9 1 1 0 0 1
thought to thought t th tho thou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
shown in shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 1 0 0 1
jury [9, jury j ju jur jury BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [,] 3 9 1 1 0 0 1
angioplasty [11]. angioplasty a an ang angi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [].,- 5 9 1 1 0 0 1
rats after rats r ra rat rats BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
thickening [12]. thickening t th thi thic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []. 3 9 1 1 0 0 1
to result to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 1 1 0 0 1
of Ras of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []. 3 10 1 1 0 0 1
Raf/MAP kinase-ERK raf/map R Ra Raf Raf/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 /-()/ 5 8 1 1 0 0 1
signal-regulated (ERK) signal-regulated s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -()( 4 9 1 1 0 0 1
the mitogen-activated the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -[]) 4 9 1 1 0 0 1
[14], which [14], [ [1 [14 [14] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 [], 3 9 1 1 0 0 1
leads to leads l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 1 1 0 0 1
tumor suppressor tumor t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .- 2 9 1 1 0 0 1
tivates the tivates t ti tiv tiva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
transcription factors, transcription t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
activate the activate a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
essential for essential e es ess esse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
from G1 from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []., 4 9 1 1 0 0 1
PDGF has pdgf P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
injury by injury i in inj inju BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 1 1 0 0 1
thereby causing thereby t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 1 1 0 0 1
differentiation and differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
lesion. lesion. lesion. l le les lesi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 1 1 1 0 0 1
Vascular endothelial vascular V Va Vas Vasc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ()- 3 8 1 1 0 0 1
kDa dimeric kda k kD kDa kDa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 []- 3 9 1 1 0 0 1
esis (sprouting esis e es esi esis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 10 1 1 0 0 1
and vasculogenesis and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 1 1 0 0 1
[17, 18]. [17, [ [1 [17 [17, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 [,]. 4 9 1 1 0 0 1
regulated by regulated r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,-[] 4 9 1 1 0 0 1
and Flk-1/KDR and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -/[], 5 9 1 1 0 0 1
proliferation, antiapoptosis, proliferation, p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,,- 3 9 1 1 0 0 1
thelial cells thelial t th the thel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [,,]. 5 9 1 1 0 0 1
VEGF have vegf V VE VEG VEGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
artery formation artery a ar art arte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
deficits such deficits d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
peripheral vascular peripheral p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [,]., 5 9 1 1 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 1 1 0 0 1
cular protective cular c cu cul cula BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
treatment of treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []. 3 9 1 1 0 0 1
Specifically, it specifically, S Sp Spe Spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
that VEGF that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 7 1 1 0 0 1
re-endothelialization and re-endothelialization r re re- re-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -,- 3 9 1 1 0 0 1
pothesized that pothesized p po pot poth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 7 1 1 0 0 1
endothelialization, neointimal endothelialization, e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
[26 –30]. [26 [ [2 [26 [26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 [–]. 4 1 1 1 0 0 1
Evidence suggests evidence E Ev Evi Evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 8 1 1 0 0 1
Flk-1/KDR, are flk-1/kdr, F Fl Flk Flk- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -/, 3 9 1 1 0 0 1
but are but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [–]. 4 10 1 1 0 0 1
Moreover, two moreover, M Mo Mor More BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 1 1 0 0 1
tional VEGF tional t ti tio tion BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 - 1 9 1 1 0 0 1
gration but gration g gr gra grat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 [,].,- 6 10 1 1 0 0 1
fect of fect f fe fec fect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 - 1 9 1 1 0 0 1
is unknown. is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 2 1 1 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 5 , 1 9 1 1 0 0 1
PDGF-BB-induced proliferation pdgf-bb-induced P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 -- 2 8 1 1 0 0 1
bromo deoxy bromo b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ().- 4 9 1 1 0 0 1
thermore, we thermore, t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 , 1 9 1 1 0 0 1
that VEGF that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 --- 3 8 1 1 0 0 1
tion of tion t ti tio tion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 /. 2 5 1 1 0 0 1
MATERIALS AND materials M MA MAT MATE BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 1 1 0 0 1
Reagents Reagents reagents R Re Rea Reag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 10 1 1 0 0 1
Human recombinant human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 - 1 8 1 1 0 0 1
PeproTech (Rocky peprotech P Pe Pep Pepr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 (,)., 5 9 1 1 0 0 1
basal media basal b ba bas basa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (),()- 6 9 1 1 0 0 1
ing 0.5 ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 2 6 ./,/,/, 7 8 1 1 0 0 1
g/mL amphotericin-B, g/ml g g/ g/m g/mL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 /-,/,, 6 9 1 1 0 0 1
0.025% tryspin/0.01% 0.025% 0 0. 0.0 0.02 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 ./.,, 5 10 1 1 0 0 1
and HEPES-buffered and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 --- 3 9 1 1 0 0 1
ics Biowhittaker ics i ic ics ics BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (,).- 5 9 1 1 0 0 1
tibodies were tibodies t ti tib tibo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 :() 3 9 1 1 0 0 1
(554136) from (554136) ( (5 (55 (554 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 ()(,), 6 8 1 1 0 0 1
-smooth muscle -smooth - -s -sm -smo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 -(-)(.,) 8 9 1 1 0 0 1
ERK2 (E-4) erk2 E ER ERK ERK2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 (-)/(-) 7 8 1 1 0 0 1
(Santa Cruz, (santa ( (S (Sa (San BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (,).- 5 9 1 1 0 0 1
ish peroxidase ish i is ish ish BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (,). 4 9 1 1 0 0 1
concentration assay concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -(- 3 9 1 1 0 0 1
cules, CA). cules, c cu cul cule BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,).(,). 7 9 1 1 0 0 1
Nitrocellulose membrane nitrocellulose N Ni Nit Nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 (, 2 9 1 1 0 0 1
NH). All nh). N NH NH) NH). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 ).(., 5 9 1 1 0 0 1
MO), unless mo), M MO MO) MO), BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 ),. 3 4 1 1 0 0 1
Cell Culture cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 1 1 0 0 1
VSMCs were vsmcs V VS VSM VSMC BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 8 1 1 0 0 1
37°C in 37°c 3 37 37° 37°C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 8 1 1 0 0 1
bovine serum bovine b bo bov bovi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 9 1 1 0 0 1
devoid of devoid d de dev devo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 9 1 1 0 0 1
serum starvation. serum s se ser seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .. 2 8 1 1 0 0 1
Trypsin/EDTA was trypsin/edta T Tr Try Tryp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 /- 2 8 1 1 0 0 1
trypsin neutralizing trypsin t tr try tryp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 . 1 10 1 1 0 0 1
passage number passage p pa pas pass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 –. 2 9 1 1 0 0 1
reached 60 reached r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 –, 2 9 1 1 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 . 1 9 1 1 0 0 1
Cells were cells C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 -() 3 9 1 1 0 0 1
the following the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ./- 3 8 1 1 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,,,,/ 6 10 1 1 0 0 1
of SmBM of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 -. 2 3 1 1 0 0 1
BrdU Incorporation brdu B Br Brd BrdU BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 1 1 0 0 1
Cells were cells C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 -/,- 4 9 1 1 0 0 1
starved, and starved, s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ,. 2 9 1 1 0 0 1
proliferation assay proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 (;,, 4 9 1 1 0 0 1
MA) was ma) M MA MA) MA) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 )'- 3 9 1 1 0 0 1
poration into poration p po por pora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 . 1 10 1 1 0 0 1
the time the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 9 1 1 0 0 1
label for label l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 - 1 9 1 1 0 0 1
analysis. A analysis. a an ana anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 9 1 1 0 0 1
180 180 180 1 18 180 180 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 1 1 0 0 0
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 :.,., 5 10 1 1 1 1 0
incorporation. In incorporation. i in inc inco BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .,, 3 10 1 1 0 0 1
and time and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,- 2 9 1 1 0 0 1
sion. sion. sion. s si sio sion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 0 1 1 0 0 1
Western Blot western W We Wes West BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 1 1 0 0 1
VSMC were vsmc V VS VSM VSMC BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 –/- 3 8 1 1 0 0 1
dishes. After dishes. d di dis dish BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 1 1 0 0 1
liquid N liquid l li liq liqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .-( 3 9 1 1 0 0 1
mM Tris-HCL, mm m mM mM mM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,.,,., 7 8 1 1 0 0 1
Nonidet P-40) nonidet N No Non Noni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -)(/),(/), 10 9 1 1 0 0 1
10 mM 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 ,,- 3 8 1 1 0 0 1
ylsulfonylfluoride was ylsulfonylfluoride y yl yls ylsu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 10 1 1 0 0 1
transferred into transferred t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .-. 3 9 1 1 0 0 1
incubated on incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
100,000 g 100,000 1 10 100 100, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 ,,. 3 9 1 1 0 0 1
protein content protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
spectrophotometric protein spectrophotometric s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (-). 4 9 1 1 0 0 1
samples were samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
concentrations in concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (/). 4 9 1 1 0 0 1
boiled for boiled b bo boi boil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 1 0 0 1
loaded into loaded l lo loa load BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .(-) 4 9 1 1 0 0 1
(ERK-2 and (erk-2 ( (E (ER (ERK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (-)–- 5 9 1 1 0 0 1
trophoresis. The trophoresis. t tr tro trop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ..- 3 9 1 1 0 0 1
teins were teins t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
overnight at overnight o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 1 0 0 1
in Tris-buffered in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 -.. 3 9 1 1 0 0 1
Membranes were membranes M Me Mem Memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
followed by followed f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 9 1 1 0 0 1
ondary antibody ondary o on ond onda BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
the chemiluminescence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 1 1 0 0 1
radiographic film. radiographic r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 .- 2 9 1 1 0 0 1
tional Institute tional t ti tio tion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 5 1 1 0 0 1
Statistical Analysis statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 10 1 1 0 0 1
Each experiment each E Ea Eac Each BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 .- 2 9 1 1 0 0 1
tical analyses tical t ti tic tica BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 - 1 10 1 1 0 0 1
comparison against comparison c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ,- 2 9 1 1 0 0 1
ple comaparisons. ple p pl ple ple BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 .. 2 9 1 1 0 0 1
A value a A A A A BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 6 .. 2 9 1 1 0 0 1
RESULTS RESULTS results R RE RES RESU BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 4 7 no 0 10 1 1 0 0 1
VEGF Inhibits vegf V VE VEG VEGF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 - 1 10 1 1 0 0 1
A BrdU a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 7 - 1 9 1 1 0 0 1
liferation in liferation l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 . 1 10 1 1 0 0 1
inhibited PPDGF-BB-induced inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 -- 2 9 1 1 0 0 1
dose-dependent manner dose-dependent d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 -- 2 9 1 1 0 0 1
liferation from liferation l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 -- 2 9 1 1 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 /,,,, 5 8 1 1 0 0 1
and 5 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (-) 3 10 1 1 0 0 1
VEGF concentration vegf V VE VEG VEGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 ,,,(.),( 8 9 1 1 0 0 1
0.05), and 0.05), 0 0. 0.0 0.05 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 .),/(.),(.). 12 10 1 1 0 0 1
Results are results R Re Res Resu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 7 . 1 6 1 1 0 0 1
Cell Viability cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 no 0 10 1 1 0 0 1
Cell viability, cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 ,, 2 10 1 1 0 0 1
was 98% was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 . 1 9 1 1 0 0 1
There was there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 no 0 10 1 1 0 0 1
on trypan on o on on on BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 . 1 4 1 1 0 0 1
FIG. 1. fig. F FI FIG FIG. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 ..--.(), 8 9 1 1 0 0 1
incubated with incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 -/.() 5 9 1 1 0 0 1
incorporation (as incorporation i in inc inco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 (). 3 10 1 1 0 0 1
determined using determined d de det dete BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 -,*.,**.. 9 6 1 1 0 0 1
181 181 181 1 18 181 181 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 1 1 0 0 0
DORAFSHAR ET dorafshar D DO DOR DORA BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 .: 2 10 1 1 1 1 0
VEGF Inhibits vegf V VE VEG VEGF BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
Western immunoblotting western W We Wes West BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 1 0 0 1
was used was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
phase. Cell phase. p ph pha phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .- 2 9 1 1 0 0 1
crease in crease c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 1 0 0 1
VEGF inhibited vegf V VE VEG VEGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 --- 3 8 1 1 0 0 1
tion in tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(.).- 6 9 1 1 0 0 1
western immunoblot western w we wes west BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 1 0 0 1
confirm equivalent confirm c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .- 2 9 1 1 0 0 1
sitometry revealed sitometry s si sit sito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 9 1 1 0 0 1
phorylation from phorylation p ph pho phor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 .-.-- 5 9 1 1 0 0 1
line with line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -/ 2 9 1 1 0 0 1
1.5 0.19-, 1.5 1 1. 1.5 1.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ..-,..-,..-,..-,. 17 9 1 1 0 0 1
0.05%-fold increase 0.05%-fold 0 0. 0.0 0.05 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .-- 3 8 1 1 0 0 1
centration of centration c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,,(.)/( 8 9 1 1 0 0 1
0.01), respectively 0.01), 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .),(.). 7 10 1 1 0 0 1
mean SD. mean m me mea mean BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 1 1 1 0 0 1
VEGF Inhibits vegf V VE VEG VEGF BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 / 1 10 1 1 0 0 1
ERK 1/2 erk E ER ERK ERK BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 / 1 8 1 1 0 0 1
whether VEGF whether w wh whe whet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 1 1 0 0 1
through the through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 10 1 1 0 0 1
PDGF-BB-induced stimulation pdgf-bb-induced P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 -- 2 9 1 1 0 0 1
of phosphorylation of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 /. 2 10 1 1 0 0 1
PDGF-BB-induced ERK pdgf-bb-induced P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 --/- 4 9 1 1 0 0 1
dependent manner dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (.).- 5 9 1 1 0 0 1
blot densitometry blot b bl blo blot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 1 0 0 1
difference in difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 10 1 1 0 0 1
revealed significant revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 /- 2 9 1 1 0 0 1
lation from lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 .-.- 4 9 1 1 0 0 1
with PDGF-BB with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -/. 3 9 1 1 0 0 1
0.31-, 1.2 0.31-, 0 0. 0.3 0.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .-,..-,..-,..-,. 16 9 1 1 0 0 1
0.06-fold increase 0.06-fold 0 0. 0.0 0.06 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .-- 3 9 1 1 0 0 1
tions of tions t ti tio tion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ,,(.),(.), 10 9 1 1 0 0 1
FIG. 2. fig. F FI FIG FIG. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 ..-.(), 7 9 1 1 0 0 1
PDGF-BB 20 pdgf-bb P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 -/.,- 5 9 1 1 0 0 1
decrease in decrease d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -.,.., 6 10 1 1 0 0 1
incubated with incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 .,..,-. 7 9 1 1 0 0 1
remaining lanes remaining r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ///., 5 9 1 1 0 0 1
of Rb of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .() 3 9 1 1 0 0 1
conditions. Significance conditions. c co con cond BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .-,*.,**.. 10 8 1 1 0 0 1
182 182 182 1 18 182 182 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 1 1 0 0 0
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 :.,., 5 10 1 1 1 0 0
ng/mL (P ng/ml n ng ng/ ng/m BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 /(.;.). 7 10 1 1 0 0 1
mean SD. mean m me mea mean BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 1 1 1 0 0 1
CONCLUSION CONCLUSION conclusion C CO CON CONC BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 1 1 0 0 1
Previous studies previous P Pr Pre Prev BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 1 1 0 0 1
vascular protective vascular v va vas vasc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 - 1 10 1 1 0 0 1
peutic angiogenesis. peutic p pe peu peut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 9 1 1 0 0 1
model, delivery model, m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 1 1 0 0 1
gene transfer gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 0 - 1 7 1 1 0 0 1
endothelialization and endothelialization e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 - 1 9 1 1 0 0 1
sia [26, sia s si sia sia BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 [,].- 5 9 1 1 0 0 1
plantation in plantation p pl pla plan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 1 1 0 0 1
intravenous VEGF intravenous i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 1 1 0 0 1
re-endothelialization, decreased re-endothelialization, r re re- re-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 -,, 3 9 1 1 0 0 1
and reduced and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 [,]. 4 9 1 1 0 0 1
evidence of evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 9 1 1 0 0 1
perplasia following perplasia p pe per perp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 []. 3 9 1 1 0 0 1
However, this however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 ,- 2 9 1 1 0 0 1
able debate, able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,,, 3 10 1 1 0 0 1
that intravenous that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 1 1 0 0 1
iliofemoral balloon iliofemoral i il ili ilio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 - 1 10 1 1 0 0 1
creased neointimal creased c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 1 1 0 0 1
maximal collateral maximal m ma max maxi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 [].,- 5 9 1 1 0 0 1
FIG. 3. fig. F FI FIG FIG. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 ..-–/.() 8 9 1 1 0 0 1
muscle cells muscle m mu mus musc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -/., 4 9 1 1 0 0 1
immunoblots showing immunoblots i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -/.() 5 10 1 1 0 0 1
positive control, positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,..,(),..,., 12 9 1 1 0 0 1
phosphorylation of phosphorylation p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 /.() 4 9 1 1 0 0 1
to serum to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .-*.,** 7 9 1 1 0 0 1
0.01. 0.01. 0.01. 0 0. 0.0 0.01 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .. 2 0 1 1 0 0 1
183 183 183 1 18 183 183 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 10 1 1 0 0 0
DORAFSHAR ET dorafshar D DO DOR DORA BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 .: 2 10 1 1 1 0 0
other group other o ot oth othe BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
of VEGF of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
thelial cell thelial t th the thel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
aorta or aorta a ao aor aort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 10 1 1 0 0 1
increased vascular increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 []. 3 6 1 1 0 0 1
Despite the despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 1 1 0 0 1
evidence points evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 1 1 0 0 1
endothelialization and endothelialization e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
after balloon-induced after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -,- 3 9 1 1 0 0 1
tion and tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ..- 3 10 1 1 0 0 1
esized that esized e es esi esiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
neointimal hyperplasia neointimal n ne neo neoi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
liferating action liferating l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
re-endothelialization of re-endothelialization r re re- re-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -, 2 10 1 1 0 0 1
re-endothelialization secondarily re-endothelialization r re re- re-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
hyperplasia [26]. hyperplasia h hy hyp hype BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 [].,- 5 8 1 1 0 0 1
formed using formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
VSMC proliferation vsmc V VS VSM VSMC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (- 2 9 1 1 0 0 1
tion) in tion) t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ), 2 10 1 1 0 0 1
soaking the soaking s so soa soak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 1 1 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 10 1 1 0 0 1
intimal VSMC intimal i in int inti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 []. 3 8 1 1 0 0 1
VEGF may vegf V VE VEG VEGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 8 1 1 0 0 1
dent of dent d de den dent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 . 1 8 1 1 0 0 1
Interestingly, Taniguchi interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ,., 3 9 1 1 0 0 1
a cell a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
cells, addition cells, c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 8 1 1 0 0 1
PDGF-BB stimulated pdgf-bb P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
in proliferation in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 - 1 8 1 1 0 0 1
tions of tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -[]. 4 8 1 1 0 0 1
may negatively may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
tion induced tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -., 3 9 1 1 0 0 1
investigators did investigators i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
to elucidate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
suppressing PDGF-BB suppressing s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -.- 3 9 1 1 0 0 1
ally, Hu ally, a al all ally BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,.-, 4 9 1 1 0 0 1
from VEGF from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
the signal the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 9 1 1 0 0 1
human aortic human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 9 1 1 0 0 1
pothesized that pothesized p po pot poth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 []. 3 4 1 1 0 0 1
Our experiments our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
has a has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
VSMC. PDGF vsmc. V VS VSM VSMC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 7 1 1 0 0 1
because it because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
an important an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
lesion [9 lesion l le les lesi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 [–]., 5 9 1 1 0 0 1
have shown have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
of VSMC, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 8 1 1 0 0 1
dependent manner. dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 8 1 1 0 0 1
assay reveals assay a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
paralleled by paralleled p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -- 2 8 1 1 0 0 1
phorylation. This phorylation. p ph pho phor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 1 1 0 0 1
to pass to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 10 1 1 0 0 1
thus were thus t th thu thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 9 1 1 0 0 1
phorylation was phorylation p ph pho phor BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 8 1 1 0 0 1
manner suggesting manner m ma man mann BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 no 0 8 1 1 0 0 1
from ERK from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .- 2 8 1 1 0 0 1
ther studies ther t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
of action of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 , 1 8 1 1 0 0 1
it acts it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 --/ 3 9 1 1 0 0 1
whether it whether w wh whe whet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
level. The level. l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .- 2 8 1 1 0 0 1
cause VEGF cause c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -- 2 8 1 1 0 0 1
and also and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 [].- 4 9 1 1 0 0 1
tional investigations tional t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 no 0 8 1 1 0 0 1
whether VEGF whether w wh whe whet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ., 2 8 1 1 0 0 1
however, is however, h ho how howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,- 2 9 1 1 0 0 1
creased proliferation creased c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -- 2 9 1 1 0 0 1
ence of ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 - 1 8 1 1 0 0 1
able or able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 10 1 1 0 0 1
arms, as arms, a ar arm arms BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,. 2 9 1 1 0 0 1
However, this however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 ,, 2 9 1 1 0 0 1
inadequate test inadequate i in ina inad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
observed phenomenon observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
detailed investigation detailed d de det deta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
other markers other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 4 1 1 0 0 1
In summary, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 5 , 1 8 1 1 0 0 1
have direct have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
and that and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 10 1 1 0 0 1
This occurs this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 8 1 1 0 0 1
In addition in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 5 -, 2 9 1 1 0 0 1
this is this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 8 1 1 0 0 1
nism of nism n ni nis nism BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 - 1 8 1 1 0 0 1
proliferation following proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 9 1 1 0 0 1
ating the ating a at ati atin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 . 1 8 1 1 0 0 1
Moreover, VEGF moreover, M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 ,- 2 8 1 1 0 0 1
ulator of ulator u ul ula ulat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 -.- 3 8 1 1 0 0 1
ther investigation ther t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 no 0 9 1 1 0 0 1
the exact the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,,, 3 9 1 1 0 0 1
insight may insight i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 8 1 1 0 0 1
PDGF and pdgf P PD PDG PDGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 no 0 8 1 1 0 0 1
regulatory response regulatory r re reg regu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 6 1 1 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 10 1 1 0 0 1
1. Fischman, 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,..,,..,,..,,..,, 18 10 1 1 0 0 1
M. P., m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ..,,.,,.,,.,,.,,., 18 9 1 1 0 0 1
Cleman, M., cleman, C Cl Cle Clem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ,.,,.,,.,,..,, 14 8 1 1 0 0 1
R. D., r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ..,,.,,.,,.,,., 15 8 1 1 0 0 1
Hirshfeld, J., hirshfeld, H Hi Hir Hirs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ,.,,.,,.,,.,,. 14 10 1 1 0 0 1
the STRESS the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 7 1 1 0 0 1
coronary-stent placement coronary-stent c co cor coro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 -- 2 8 1 1 0 0 1
ment of ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 .....:, 7 8 1 1 0 0 1
1994. 1994. 1994. 1 19 199 1994 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 9 . 1 0 1 1 0 0 1
2. Healy, 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,..,,..,,..- 13 9 1 1 0 0 1
follow-up and follow-up f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -... 4 9 1 1 0 0 1
Surg. 10: surg. S Su Sur Surg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 .:,. 4 5 1 1 0 0 1
3. Clowes, 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,..,,..,,.. 12 8 1 1 0 0 1
cellular proliferation cellular c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 .. 2 9 1 1 0 0 1
growth in growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ...:, 5 8 1 1 0 0 1
1983. 1983. 1983. 1 19 198 1983 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 9 . 1 0 1 1 0 0 1
4. Clowes, 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,..,,..,,.. 12 9 1 1 0 0 1
stenosis after stenosis s st ste sten BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 ...:,. 6 8 1 1 0 0 1
5. Dicorleto, 5. 5 5. 5. 5. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,..,-,.. 9 9 1 1 0 0 1
184 184 184 1 18 184 184 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 10 1 1 0 0 0
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 :.,., 5 10 1 1 1 0 0
cells produce cells c ce cel cell BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 --.. 4 10 1 1 0 0 1
Natl. Acad. natl. N Na Nat Natl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ...:,. 6 5 1 1 0 0 1
6. Nilsson, 6. 6 6. 6. 6. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,,.,,.,,.,, 14 10 1 1 0 0 1
C. H. c. C C. C. C. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .. 2 9 1 1 0 0 1
platelet-derived growth platelet-derived p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 --.... 6 9 1 1 0 0 1
Sci. USA sci. S Sc Sci Sci. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .:,. 4 3 1 1 0 0 1
7. Shimokado, 7. 7 7. 7. 7. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,,..,,..,,.., 16 10 1 1 0 0 1
Benditt, E. benditt, B Be Ben Bend BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..,,.- 7 9 1 1 0 0 1
derived growth derived d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 9 1 1 0 0 1
Cell 43: cell C Ce Cel Cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 :,. 3 3 1 1 0 0 1
8. Kaplan, 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,..,,..,,..,,.., 17 10 1 1 0 0 1
Scher, C. scher, S Sc Sch Sche BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..- 4 8 1 1 0 0 1
fibroblasts. Blood fibroblasts. f fi fib fibr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .:,. 4 5 1 1 0 0 1
9. Uchida, 9. 9 9. 9. 9. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,.,,.,,.,,.,- 14 10 1 1 0 0 1
noshita, M. noshita, n no nos nosh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,.- 3 9 1 1 0 0 1
B-chain in b-chain B B- B-c B-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 - 1 9 1 1 0 0 1
rabbit femoral rabbit r ra rab rabb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .:,. 4 8 1 1 0 0 1
10. Majesky, 10. 1 10 10. 10. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,..,,..,-,..,,.., 18 10 1 1 0 0 1
Wilcox, J. wilcox, W Wi Wil Wilc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 ,..,,.. 7 9 1 1 0 0 1
gene expression gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 1 ... 3 9 1 1 0 0 1
111: 2149, 111: 1 11 111 111: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 :,. 3 2 1 1 0 0 1
11. Ueda, 11. 1 11 11. 11. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,.,,..,,.,,.,,., 17 10 1 1 0 0 1
and Tanaka, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ,.- 3 8 1 1 0 0 1
factor-A and factor-a f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 -- 2 8 1 1 0 0 1
percutaneous transluminal percutaneous p pe per perc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 ... 3 8 1 1 0 0 1
Pathol. 149: pathol. P Pa Pat Path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 .:,. 4 3 1 1 0 0 1
12. Jawien, 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,.,-,..,,.,,.., 16 10 1 1 0 0 1
and Clowes, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ,..- 4 8 1 1 0 0 1
smooth muscle smooth s sm smo smoo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 9 1 1 0 0 1
of balloon of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ....:,. 7 8 1 1 0 0 1
13. Schlessinger, 13. 1 13 13. 13. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,.. 4 10 1 1 0 0 1
Trends Biochem. trends T Tr Tre Tren BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 ..:,. 5 5 1 1 0 0 1
14. Seger, 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,... 8 10 1 1 0 0 1
FASEB J. faseb F FA FAS FASE BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 .:,. 4 3 1 1 0 0 1
15. Nevins, 15. 1 15 15. 15. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..- 5 10 1 1 0 0 1
plexity of plexity p pl ple plex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 . 1 9 1 1 0 0 1
Differ. 9: differ. D Di Dif Diff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 .:,. 4 3 1 1 0 0 1
16. Ferrara, 16. 1 16 16. 16. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.. 7 10 1 1 0 0 1
a novel a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 3 -- 2 9 1 1 0 0 1
dothelial cells. dothelial d do dot doth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 .....:, 7 8 1 1 0 0 1
1989. 1989. 1989. 1 19 198 1989 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 . 1 0 1 1 0 0 1
17. Ferrara, 17. 1 17 17. 17. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.... 6 10 1 1 0 0 1
32A: 2413, 32a: 3 32 32A 32A: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 :,. 3 2 1 1 0 0 1
18. Risau, 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..:,. 7 10 1 1 0 0 1
19. de 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,.,,..,,.,,.,,., 17 10 1 1 0 0 1
and Williams, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 ,..-, 5 9 1 1 0 0 1
vascular endothelial vascular v va vas vasc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 ..:,. 5 8 1 1 0 0 1
20. Millauer, 20. 2 20 20. 20. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,.,-,.,,.,,., 14 10 1 1 0 0 1
Moller, N. moller, M Mo Mol Moll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ,...,,.,,. 10 9 1 1 0 0 1
binding and binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 - 1 9 1 1 0 0 1
regulator of regulator r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 .:, 3 9 1 1 0 0 1
1993. 1993. 1993. 1 19 199 1993 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 4 . 1 0 1 1 0 0 1
21. Gerber, 21. 2 21 21. 21. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,..,,.,,. 10 10 1 1 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 no 0 9 1 1 0 0 1
Bcl-2 and bcl-2 B Bc Bcl Bcl- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 -....: 6 9 1 1 0 0 1
13313, 1998. 13313, 1 13 133 1331 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 4 ,. 2 1 1 1 0 0 1
22. Gerber, 22. 2 22 22. 22. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,..,,.,,.,,.,, 15 10 1 1 0 0 1
B. A., b. B B. B. B. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..,,.,,. 8 9 1 1 0 0 1
factor regulates factor f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 10 1 1 0 0 1
tidylinositol 3-kinase/Akt tidylinositol t ti tid tidy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -/. 3 8 1 1 0 0 1
J. Biol. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ...:,. 6 5 1 1 0 0 1
23. Hockel, 23. 2 23 23. 23. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,.,,.,,.,,.,, 14 10 1 1 0 0 1
P. Therapeutic p. P P. P. P. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ....:,. 7 8 1 1 0 0 1
24. Isner, 24. 2 24 24. 24. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,..,,.. 8 8 1 1 0 0 1
heart failure. heart h he hea hear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...:,. 6 5 1 1 0 0 1
25. Zachary, 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.- 4 8 1 1 0 0 1
tive actions tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ... 3 7 1 1 0 0 1
Physiol. Cell. physiol. P Ph Phy Phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ...:,. 6 5 1 1 0 0 1
26. Asahara, 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,., 16 9 1 1 0 0 1
Bunting, S., bunting, B Bu Bun Bunt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.,,.,,.,,.. 12 8 1 1 0 0 1
delivery of delivery d de del deli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 1 1 0 0 1
dothelialization and dothelialization d do dot doth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 1 1 0 0 1
injured rat injured i in inj inju BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .:,. 4 7 1 1 0 0 1
27. Asahara, 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,., 16 8 1 1 0 0 1
Passeri, J., passeri, P Pa Pas Pass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,..,,..- 11 8 1 1 0 0 1
tution of tution t tu tut tuti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 7 1 1 0 0 1
function after function f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .: 2 7 1 1 0 0 1
3291, 1996. 3291, 3 32 329 3291 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,. 2 1 1 1 0 0 1
28. Van 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.,,.,,., 17 10 1 1 0 0 1
and Isner, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,..:, 5 8 1 1 0 0 1
local catheter local l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,- 2 8 1 1 0 0 1
ministration, and ministration, m mi min mini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,. 2 8 1 1 0 0 1
95: 438, 95: 9 95 95: 95: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 :,. 3 2 1 1 0 0 1
29. Van 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.,,.,,., 17 9 1 1 0 0 1
and Isner, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.. 3 8 1 1 0 0 1
gene transfer gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 5 no 0 7 1 1 0 0 1
intimal thickening. intimal i in int inti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .....:,. 8 7 1 1 0 0 1
30. Luo, 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,..,,.. 17 9 1 1 0 0 1
Reduction of reduction R Re Red Redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 1 0 0 1
endothelium-dependent relaxation endothelium-dependent e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 -- 2 8 1 1 0 0 1
lial growth lial l li lia lial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ....:,. 7 6 1 1 0 0 1
31. Guerrin, 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,., 16 8 1 1 0 0 1
Malecaze, F., malecaze, M Ma Mal Male BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,./ 6 8 1 1 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 1 0 0 1
pigment epithelial pigment p pi pig pigm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ....: 5 9 1 1 0 0 1
385, 1995. 385, 3 38 385 385, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,. 2 1 1 1 0 0 1
32. Oberg-Welsh, 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .-,.,,.,,.,,. 13 8 1 1 0 0 1
Effects of effects E Ef Eff Effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 1 0 0 1
cell replication cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 9 1 1 0 0 1
clusters in clusters c cl clu clus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ....:,. 7 7 1 1 0 0 1
33. Sondell, 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,. 9 8 1 1 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 1 0 0 1
outgrowth, enhancing outgrowth, o ou out outg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,- 2 8 1 1 0 0 1
tion in tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ...:, 5 8 1 1 0 0 1
1999. 1999. 1999. 1 19 199 1999 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 . 1 0 1 1 0 0 1
34. Ishida, 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,., 16 9 1 1 0 0 1
Shibuya, M., shibuya, S Sh Shi Shib BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,..- 7 8 1 1 0 0 1
thelial growth thelial t th the thel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ... 3 8 1 1 0 0 1
Physiol. 188: physiol. P Ph Phy Phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .:,. 4 3 1 1 0 0 1
35. Grosskreutz, 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,-,.,,.,,.,- 15 8 1 1 0 0 1
man, B. man, m ma man man, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,..,,.,',.. 11 8 1 1 0 0 1
growth factor-induced growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 7 1 1 0 0 1
cells in cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...:,. 6 6 1 1 0 0 1
36. Luo, 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,..,,.. 17 9 1 1 0 0 1
Reduction of reduction R Re Red Redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 1 0 0 1
endothelium-dependent relaxation endothelium-dependent e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 -- 2 8 1 1 0 0 1
lial growth lial l li lia lial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ....:,. 7 6 1 1 0 0 1
37. Lazarous, 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,..,,.,,.,,.,- 15 8 1 1 0 0 1
murti, V., murti, m mu mur murt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,..,,..,,..,, 16 9 1 1 0 0 1
S., Guetta, s., S S. S., S., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,.,,..,,.. 12 8 1 1 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 9 1 1 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 1 1 0 0 1
rial response rial r ri ria rial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .:,. 4 7 1 1 0 0 1
38. Lindner, 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.. 7 8 1 1 0 0 1
arteries after arteries a ar art arte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 1 1 0 0 1
lial regrowth lial l li lia lial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .... 4 8 1 1 0 0 1
Biol. 16: biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .:,. 4 2 1 1 0 0 1
39. Laitinen, 39. 3 39 39. 39. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,- 14 8 1 1 0 0 1
185 185 185 1 18 185 185 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 1 1 0 0 0
DORAFSHAR ET dorafshar D DO DOR DORA BLOCKSTART PAGEEND SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 .: 2 10 1 1 1 0 0
nen, T., nen, n ne nen nen, BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.,,.,,.,,.,,.,, 16 8 1 1 0 0 1
M., Martin, m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,..,-,. 9 9 1 1 0 0 1
reduces intimal reduces r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 1 1 0 0 1
oxide in oxide o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ..:,. 5 8 1 1 0 0 1
40. Taniguchi, 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,.,,.,,.,,. 15 10 1 1 0 0 1
Human uterine human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 1 0 0 1
and vascular and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -- 2 8 1 1 0 0 1
sponse to sponse s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -...: 5 9 1 1 0 0 1
79, 2001. 79, 7 79 79, 79, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,. 2 1 1 1 0 0 1
41. Hu, 41. 4 41 41. 41. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,..,,.,,.,,., 18 10 1 1 0 0 1
Coleman, T. coleman, C Co Col Cole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.. 3 8 1 1 0 0 1
cleaved VEGF-2 cleaved c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 - 1 8 1 1 0 0 1
cells. FASEB. cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ...:,. 6 4 1 1 0 0 1
42. Muller, 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,.,,..,,..,- 17 9 1 1 0 0 1
ham, B. ham, h ha ham ham, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ,..,,.. 7 8 1 1 0 0 1
factor: crystal factor: f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 : 1 9 1 1 0 0 1
domain receptor domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 .....: 6 8 1 1 0 0 1
7192, 1997. 7192, 7 71 719 7192 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ,. 2 1 1 1 0 0 1
186 186 186 1 18 186 186 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 1 1 0 0 0
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 :.,., 5 10 1 1 1 0 0

